SAN DIEGO, Feb. 7, 2012 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company’s Chief Executive Officer, Brian M. Culley, will present at the 14th Annual BIO CEO & Investor Conference on Tuesday, February 14, 2012 at 11:00 a.m. Eastern time, in the Park South Salon at the Waldorf=Astoria Hotel in New York.
Interested parties can access a live audio webcast and slide presentation on the ADVENTRX Pharmaceuticals web site at www.adventrx.com. An archived presentation will be available on the web site for 30 days.
About ADVENTRX Pharmaceuticals
ADVENTRX Pharmaceuticals is a biopharmaceutical company focused on developing proprietary product candidates. The Company’s lead product candidate is ANX-188, a rheologic, antithrombotic and cytoprotective agent that improves micro-vascular blood flow, which has potential application in treating a wide range of diseases and conditions, such as complications arising from sickle cell disease. The Company also is developing ANX-514, a novel, detergent-free formulation of the chemotherapy drug docetaxel. More information can be found on the Company’s web site at www.adventrx.com.
SOURCE ADVENTRX Pharmaceuticals, Inc.
